Published in J Natl Cancer Inst on August 19, 1998
An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J (2008) 1.97
Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med (2005) 1.51
Chemoprevention of head and neck cancer with green tea polyphenols. Cancer Prev Res (Phila) (2010) 1.00
Palliative interventional pulmonology procedures in the incarcerated population with cancer: a case series. Lung (2014) 0.75
Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst (1998) 2.34
5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med (1995) 9.10
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res (1995) 7.42
Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med (1995) 5.10
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet (1995) 3.76
The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev (1999) 3.54
Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation (1996) 3.34
Retracted Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study. Lancet (2005) 3.13
Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst (2000) 2.39
Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res (2000) 2.34
Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers. J Natl Cancer Inst (2001) 2.18
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. J Clin Endocrinol Metab (1998) 2.17
Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science (1994) 2.16
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest (2001) 2.03
A deep-coverage tomato BAC library and prospects toward development of an STC framework for genome sequencing. Genome Res (2000) 1.95
The Mla (powdery mildew) resistance cluster is associated with three NBS-LRR gene families and suppressed recombination within a 240-kb DNA interval on chromosome 5S (1HS) of barley. Genetics (1999) 1.93
Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol (1996) 1.90
Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci U S A (1997) 1.88
Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol (1996) 1.84
Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res (2000) 1.81
Survival of infants with malignant astrocytomas. A Report from the Childrens Cancer Group. Cancer (1995) 1.67
ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol (1994) 1.66
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology (1998) 1.66
Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol (1998) 1.61
Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: the Health in Men Study. Sex Transm Infect (2006) 1.59
Cellular and functional defects in a mouse model of heart failure. Am J Physiol Heart Circ Physiol (2000) 1.49
HIV risk and communication between regular partners in a cohort of HIV-negative gay men. AIDS Care (2006) 1.49
Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation (2001) 1.46
Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J Biol Chem (2000) 1.43
Mechanics and dynamics of the strain-induced M1-M2 structural phase transition in individual VO₂ nanowires. Nano Lett (2011) 1.42
Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice. J Immunol (1996) 1.38
Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Cancer Res (1996) 1.25
Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res (2001) 1.24
Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc. Cancer Res (1998) 1.23
Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem (1997) 1.23
Loss of PTEN expression as a prognostic marker for tongue cancer. Arch Otolaryngol Head Neck Surg (2001) 1.23
Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells. Gene (1997) 1.22
Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene (1997) 1.22
DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res (1996) 1.22
Digital respirosonography. New images of lung sounds. Chest (1989) 1.20
Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP Superfamily. J Clin Endocrinol Metab (1999) 1.19
Sustained expression of human factor VIII in mice using a parvovirus-based vector. Blood (2000) 1.19
Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int (1986) 1.18
Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice. Clin Cancer Res (2000) 1.18
Self-report is a valid measure of circumcision status in homosexual men. Sex Transm Infect (2008) 1.18
Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res (1995) 1.17
Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. Endocrinology (1999) 1.16
p53 gene mutations as markers of tumor spread in synchronous oral cancers. Arch Otolaryngol Head Neck Surg (1994) 1.15
Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines. Oncogene (1998) 1.15
Global gene expression during nitrogen starvation in the rice blast fungus, Magnaporthe grisea. Fungal Genet Biol (2006) 1.13
Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy. AIDS Behav (2015) 1.13
An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis. Clin Nephrol (1994) 1.12
Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J Am Coll Cardiol (2001) 1.12
Comparison of the antinociceptive effects induced by electroacupuncture and transcutaneous electrical nerve stimulation in the rat. Int J Neurosci (1994) 1.11
Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res (2001) 1.08
Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg (1994) 1.07
Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn (2001) 1.07
Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat Med (1997) 1.07
The changes in expression of three subtypes of TTX sensitive sodium channels in sensory neurons after spinal nerve ligation. Brain Res Mol Brain Res (2001) 1.07
Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development. Clin Cancer Res (2001) 1.05
Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the beta2-adrenergic receptor is associated with reduced phospholamban protein. J Clin Invest (1996) 1.05
Developments in mucosal influenza virus vaccines. Vaccine (1994) 1.04
Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Clin Cancer Res (2000) 1.04
Gay men who are not getting tested for HIV. AIDS Behav (2012) 1.04
Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J Clin Endocrinol Metab (1994) 1.03
Tonometer utilization, accuracy, and calibration under field conditions. Arch Ophthalmol (1990) 1.03
Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. Endocrinology (2001) 1.02
Synovial fluid CD34⁻ CD44⁺ CD90⁺ mesenchymal stem cell levels are associated with the severity of primary knee osteoarthritis. Osteoarthritis Cartilage (2011) 1.01
Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice. Am J Physiol (1998) 1.01
The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells. J Biol Chem (1992) 1.01
N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res (2000) 1.00
Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res (1999) 1.00
Multiple oral squamous epithelial lesions: are they genetically related? Oncogene (2001) 1.00
Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. J Clin Endocrinol Metab (1998) 1.00
Immunocytochemical and functional characterization of Na+ conductance in adult alveolar pneumocytes. Am J Physiol (1992) 0.99
Influence of needle gauge in Mantoux skin testing. Chest (1994) 0.98
Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2. Vaccine (2011) 0.98
Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium. Endocrinology (2000) 0.97
Influence of hypertension on the progression of experimental autologous immune complex nephritis. J Lab Clin Med (1983) 0.97
Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition. Circulation (1999) 0.96
Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer. Cancer Res (1997) 0.95
The protective effect of sonic hedgehog is mediated by the phosphoinositide [corrected] 3-kinase/AKT/Bcl-2 pathway in cultured rat astrocytes under oxidative stress. Neuroscience (2012) 0.95
Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas. Cancer Res (1997) 0.95
Measurement of the neutron radius of 208Pb through parity violation in electron scattering. Phys Rev Lett (2012) 0.95
Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial. Clin Cancer Res (2013) 0.95
Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding. J Clin Endocrinol Metab (2001) 0.94
Interaction of syntaxins with the amiloride-sensitive epithelial sodium channel. J Biol Chem (1999) 0.94
Loss of Fhit expression is a predictor of poor outcome in tongue cancer. Cancer Res (2001) 0.94
Insulinlike growth factor-binding proteins. Recent Prog Horm Res (1990) 0.94
Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer. Clin Cancer Res (2000) 0.93
Comparison of the virulence of European and North American genotypes of porcine reproductive and respiratory syndrome virus in experimentally infected pigs. Vet J (2012) 0.93
Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. Vaccine (2005) 0.93
Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil. Leukemia (1997) 0.93
Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression. J Natl Cancer Inst (2000) 0.92
Force-frequency effect is a powerful determinant of myocardial contractility in the mouse. Am J Physiol (1997) 0.92
Generation and characterization of an IGFBP-7 antibody: identification of 31kD IGFBP-7 in human biological fluids and Hs578T human breast cancer conditioned media. J Clin Endocrinol Metab (1997) 0.92
CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL). Br J Cancer (2000) 0.92
Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer. Clin Cancer Res (1998) 0.92